‘One Health’ Approach Is Necessary to Address Rising Environmental Causes of Childhood Cancers

A multi-disciplinary, “One Health” approach to cancer research is necessary to guide society in reduction of toxic substances, as well as regulation of chemical impacts on the environment and public health, according to an editorial published...
6-Jul-2022 5:05 PM EDT Add to Favorites

VR-Integrated Rehab for Cancer Patients Shows Potential in Research Review

Oncology researchers using Virtual Reality (VR) in the treatment of cancer patients have published a review of the existing literature regarding the application of this technology for the rehabilitation of cancer survivors.
6-Jul-2022 3:45 PM EDT Add to Favorites

Drug Repurposing Identifies New Candidates to Treat Mesothelioma

A group of researchers have identified potential novel drug candidates for the treatment of Malignant Pleural Mesothelioma (MPM).
28-Jun-2022 9:00 AM EDT Add to Favorites

Treatment with Cell Cycle Inhibitors: Another Caveat on a Clinical Trial for Mesothelioma Red-Flagged in Lancet Oncology

There is a growing awareness that the design of clinical trials can be misleading and provide evidence that does not end up actually benefiting patients in the clinical setting.
27-Jun-2022 3:00 PM EDT Add to Favorites

Public Health Conference: 2022 Theme: Response to COVID-19 and Impact of the Pandemic

Public Health conference hosted by Temple University Rome and Temple College of Public Health.
9-May-2022 1:30 PM EDT Add to Favorites

Targeting Cervical Cancer Stem Cells to Improve Outcomes

The presence of Cervical Cancer Stem Cells (CCSCs) in cases of Cervical Cancer (CC) represent a small subpopulation of tumor cells with a high potential for resistance to conventional treatments.
6-May-2022 10:35 AM EDT Add to Favorites

New Mesothelioma Drugs, Once Hailed as Gamechangers, Don’t Live Up to the Hype

Malignant Pleural Mesothelioma (MPM) is an aggressive cancer mostly related to asbestos exposure whose incidence is constantly rising, especially in low-income countries.
10-Mar-2022 6:05 AM EST Add to Favorites

Cancer Immunotherapy Is Not the Holy Grail: A New Study Casts a Shadow

Recently approved drugs to boost the immune response against cancer represents a novelty that should not be over-hyped, researchers say
27-Dec-2021 5:05 PM EST Add to Favorites